Skip to main content
Clinical Trials/CTRI/2018/04/012949
CTRI/2018/04/012949Completed未知

Periorbital and ocular surface changes in patients on Prostaglandin Analogue eye drops.

Giridhar Eye Institute0 sites32 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
32

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • All patients on prostaglandin analogues for less than 6 months irrespective of glaucoma or combination of drugs used.

Exclusion Criteria

  • (a) Patients who has undergone any surgery other than cataract surgery (b) patients already detected with ocular surface diseases (c) patients having lid diseases like ptosis, thyroid related orbitopathy or lid tumours.

Investigators

Similar Trials